Target intelligence / Profile preview

ADAM metallopeptidase domain pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

ADAM metallopeptidase domain pseudogenes are non-coding remnants of formerly functional ADAM family genes. The ADAM (A Disintegrin and Metalloprotease) family consists of membrane-anchored proteins involved in processes such as cell adhesion, proteolysis, and signal transduction. However, ADAM pseudogenes, identified by the lack of conserved functional domains, are non-functional and do not encode active enzymes or receptors. They are not considered drug targets, do not participate directly in cellular processes, and have no known mechanisms of action or pharmacological relevance. The inclusion of "pseudogene" in the name means it is not a protein product, and the entry ENSG00000267793 lacks sufficient data to attribute specific aliases, functions, or relevance to disease or pharmacology[3][4][5][7]. If your interest is in the functional ADAM family proteins (such as ADAM10, ADAM17), those are proteases with multiple relevant biological and pathological roles[1][3]. However, for ENSG00000267793 and its generic "ADAM metallopeptidase domain pseudogene" label, it is not a drug target and carries no clinical or mechanistic significance.

Beyond the preview

Go deeper on ADAM metallopeptidase domain pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAM metallopeptidase domain pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call